Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancerAlessandra Fabi, Marcella Mottolese, Cecilia Nisticò et al.|Expert Opinion on Pharmacotherapy|2013Cited by 17
Correlation of efficacy between EGFR gene copy number and lapatinib/capecitabine therapy in HER2-positive metastatic breast cancer.Alessandra Fabi, Francesco Cognetti, A. Di Benedetto et al.|Journal of Clinical Oncology|2010Cited by 2
EGFR Gene Copy Number and Response to Lapatinib/Capecitabine in HER2 Positive Metastatic Breast Cancer Patients Pretreated with Trastuzumab.Alessandra Fabi, Francesco Cognetti, Erika Vico et al.|Cancer Research|2009Cited by 0